SKIN (SkinHealth Systems) ROE %: -45.61% (As of Mar. 2026)


SKIN SkinHealth Systems Inc SKIN
49 GF Score
Price $0.66
GF Value $1.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is SkinHealth Systems ROE %?

SkinHealth Systems SKIN +3.17% 49 ROE % is -45.61% as of Mar. 2026. GuruFocus rates SKIN with a GF Score™ of 49/100 and a GF Value™ of $1.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,916 Consumer Packaged Goods companies, SkinHealth Systems ranks worse than 85.86% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. SkinHealth Systems's annualized net income for the quarter that ended in Mar. 2026 was $-26.5 Mil. SkinHealth Systems's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $58.1 Mil. Therefore, SkinHealth Systems's annualized ROE % for the quarter that ended in Mar. 2026 was -45.61%.

The historical rank and industry rank for SkinHealth Systems's ROE % or its related term are showing as below:

SKIN' s ROE % Range Over the Past 10 Years
Min: -278.16   Med: -52.34   Max: 18.84
Current: -10.02

During the past 8 years, SkinHealth Systems's highest ROE % was 18.84%. The lowest was -278.16%. And the median was -52.34%.

SKIN's ROE % is ranked worse than
85.86% of 1916 companies
in the Consumer Packaged Goods industry
Industry Median: 6.72 vs SKIN: -10.02

SkinHealth Systems  (NAS:SKIN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-26.52/58.148
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-26.52 / 259.64)*(259.64 / 486.518)*(486.518 / 58.148)
=Net Margin %*Asset Turnover*Equity Multiplier
=-10.21 %*0.5337*8.3669
=ROA %*Equity Multiplier
=-5.45 %*8.3669
=-45.61 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-26.52/58.148
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-26.52 / -27.256) * (-27.256 / -7.204) * (-7.204 / 259.64) * (259.64 / 486.518) * (486.518 / 58.148)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.973 * 3.7835 * -2.77 % * 0.5337 * 8.3669
=-45.61 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


SkinHealth Systems ROE % Related Terms


SkinHealth Systems ROE % Historical Data

* Premium members only.

The historical data trend for SkinHealth Systems's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SkinHealth Systems ROE % Chart

SkinHealth Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial -278.16 18.84 -88.42 -52.34 -16.87

SkinHealth Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.53 131.34 -63.19 -51.16 -45.61

SKIN vs SLSN, GROV, WALD: ROE % Comparison

For the Household & Personal Products subindustry, SkinHealth Systems's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SkinHealth Systems ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, SkinHealth Systems's ROE % distribution charts can be found below:

* The bar in red indicates where SkinHealth Systems's ROE % falls into.


SKIN
49GF Score
SkinHealth Systems Inc SKIN
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SkinHealth Systems ROE % Calculation

SkinHealth Systems's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-9.519/( (51.803+61.056)/ 2 )
=-9.519/56.4295
=-16.87 %

SkinHealth Systems's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-26.52/( (61.056+55.24)/ 2 )
=-26.52/58.148
=-45.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -45.61% mean?
SkinHealth Systems (SKIN) has a ROE % of -45.61% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SkinHealth Systems and its competitors. According to the industry distribution chart, SkinHealth Systems ranks #1645 out of 1916 companies in the Consumer Packaged Goods industry, placing it in the top 85.9%.
Is SkinHealth Systems' ROE % too high?
SkinHealth Systems' current ROE % is -45.61%. Based on the distribution chart, SkinHealth Systems ranks #1645 out of 1916 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, SkinHealth Systems has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' ROE % compare to SLSN and GROV?
According to the Consumer Packaged Goods industry distribution chart, SkinHealth Systems ranks #1645 out of 1916 companies for ROE %. This places SkinHealth Systems in the lower half of its industry. The industry median ROE % is 6.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.72, based on 1,916 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SkinHealth Systems and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SkinHealth Systems's current ROE % is -45.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.50, compared to a current price of $0.66 — trading 55.9% below its estimated fair value. The current ROE % is -45.61%. SkinHealth Systems' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current ROE % is -45.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SkinHealth Systems (SKIN) Overvalued in 2026?

Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued. The current stock price of $0.66 is trading 55.9% below its estimated GF Value™ of $1.50. GuruFocus considers SkinHealth Systems to be Possible Value Trap.

Key valuation signals for SKIN:

  • ROE %: -45.61%
  • GF Value™: $1.50 vs. price of $0.66 (55.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SkinHealth Systems Business Description

Other Exchanges V7A0:Germany
Address 2165 Spring Street, Long Beach, CA, USA, 90806
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
49GF Score

Get the complete analysis for SKIN

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.66
Price
$1.50
GF Value